Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Molecular Data Inc.

Molecular Data Inc. (MKD) Stock Overview

Explore Molecular Data Inc.’s financial performance, market position, analyst ratings, and future outlook.

MKD●NASDAQ
Basic MaterialsChemicals
$0.41
$0.010(2.50%)
U.S. Market opens in 7h 38m

Molecular Data Inc. (MKD)

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-1.06
EPS (TTM)$-3.85
ROE2.68%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

MKD Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Molecular Data Inc. (NASDAQ: MKD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Molecular Data Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MKD on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Molecular Data Inc.'s NASDAQ-traded stock include a P/E ratio of -1.06 and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of MKD on the NASDAQ.

Price Performance (NASDAQ: MKD)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
-24.95%
Year-to-Date (YTD) Change
N/A
1-Year Change
144.78%
3-Year Change
-86.10%
5-Year Change
-92.49%
All-Time (Max) Change
-92.49%

Contact Information

https://www.molbase.cn
862154365166
NaN, Shanghai, NaN, 201106

Company Facts

1,890 Employees
IPO DateDec 30, 2019
CountryCN

Frequently Asked Questions